Epidemiology and Infection

Cambridge Journals Online - CUP Full-Text Page
Epidemiology and Infection (2010), 138:469-481 Cambridge University Press
Copyright © Cambridge University Press 2009
doi:10.1017/S0950268809990768

Original Papers

Varicella

Modelling the impact of varicella vaccination on varicella and zoster


M. KARHUNENa1, T. LEINOa1, H. SALOa1, I. DAVIDKINa1, T. KILPIa1 and K. AURANENa1a2 c1

a1 National Institute for Health and Welfare (THL), Department of Vaccination and Immune Protection, Helsinki, Finland
a2 University of Helsinki, Department of Mathematics and Statistics, Helsinki, Finland
Article author query
karhunen m [PubMed]  [Google Scholar]
leino t [PubMed]  [Google Scholar]
salo h [PubMed]  [Google Scholar]
davidkin i [PubMed]  [Google Scholar]
kilpi t [PubMed]  [Google Scholar]
auranen k [PubMed]  [Google Scholar]

SUMMARY

It has been suggested that the incidence of herpes zoster may increase due to lack of natural boosting under large-scale vaccination with the varicella vaccine. To study the possibility and magnitude of such negative consequences of mass vaccination, we built a mathematical model of varicella and zoster epidemiology in the Finnish population. The model was based on serological data on varicella infection, case-notification data on zoster, and new knowledge about close contacts relevant to transmission of infection. According to the analysis, a childhood programme against varicella will increase the incidence of zoster by one to more than two thirds in the next 50 years. This will be due to increase in case numbers in the xs2A7E35 years age groups. However, high vaccine coverage and a two-dose programme will be very effective in stopping varicella transmission in the population.

(Accepted August 11 2009)

(Online publication October 02 2009)

Key Words:Mathematical modelling; vaccine-preventable diseases; vaccines; varicella zoster

Correspondence:

c1 Author for correspondence: Dr K. Auranen, National Institute for Health and Welfare (THL), Department of Vaccination and Immune Protection, Mannerheimintie 166, FI-00300 Helsinki, Finland. (Email: kari.auranen@thl.fi)


Metrics
Related Content